✦ LIBER ✦

P.3.133 Risperidone long acting injectable in elderly psychotic patients: assessment of tolerability and efficacy

Book ID: 118592050
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 121 KB
Volume: 15
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(05)81069-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and efficacy of long-ac

Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients

✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a

P.3.a.015 Study of the efficacy and safe

P.3.a.015 Study of the efficacy and safety of risperidone long acting injection in elderly schizophrenia patients

✍ Y. Inoue; H. Suzuki; M. Ootomo; S. Takeda; Y. Kawaguchi; K. Gen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Long-term safety and tolerability of lon

Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder

✍ Jean-Pierre Lindenmayer; Akbar Khan; Mariëlle Eerdekens; Ilse Van Hove; Stuart K 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 443 KB

P.3.c.055 Effectiveness of long-acting i

P.3.c.055 Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients

✍ H. Kim; J. Hong 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

P.3.c.032 Long-acting risperidone inject

P.3.c.032 Long-acting risperidone injection versus conventional depots in chronic psychotic patients: a 54 months study

✍ S.L. Romero Guillena; N. Casas Barquero; J.L. Velez Noguera; R. Fernandez-Villam 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Efficacy and safety of long-acting rispe

Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder

✍ Robert A. Lasser; Cynthia A. Bossie; Young Zhu; Georges Gharabawi; Mariëlle Eerd 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## Background Elderly patients are often an underserved population in terms of optimizing treatment outcomes. Long‐acting risperidone, the first long‐acting injectable atypical antipsychotic, can improve outcomes through continuous medication delivery. ## Objective To assess the effi